Posted by Michael Wonder on 05 Aug 2015
PHARMAC is seeking feedback on a funding proposal involving five treatments for multiple sclerosis, including two new treatments that are ...
Read more →
Posted by Michael Wonder on 05 Aug 2015
CADTH has received notice of a pending submission from Vertex for Kalydeco (ivacaftor) for patients with cystic fibrosis. For information about ...
Read more →
Posted by Michael Wonder on 05 Aug 2015
GlaxoSmithKline (GSK) has welcomed the listing of Incruse Ellipta (umeclidinium) on the Australian Pharmaceutical Benefits Scheme (PBS) from December 1st ...
Read more →
Posted by Michael Wonder on 05 Aug 2015
The addition of 'Therapeutic Area" as a filter will occur soon (more on this later). To ensure that the correct therapeutic ...
Read more →
Posted by Michael Wonder on 05 Aug 2015
The recommendations made by the PBAC at its April 2015 special meeting are now available on the PBS website. ...
Read more →
Posted by Michael Wonder on 05 Aug 2015
[:content [\A \l \l \space \o \f \space \t \h \e \space \o \u \t \c \o \m \e \s \space \f \r \o \m \space \t \h \e \space \J \u \l \y \space \2 \0 \1 \3 \space \P \B \A \C \space \m \e \e \t \i \n \g \space \h \a \v \e \space \b \e \e \n \space \a \d \d \e \d \space \t \o \space \M \A \E \S \T \r \O \space \A \u \s \t \r \a \l \i \a \. \space \F \o \r \space \a \space \s \u \m \m \a \r \y \space \o \f " ..."]]
Read more →
Posted by Michael Wonder on 05 Aug 2015
[:content [\T \h \e \space \a \n \n \o \u \n \c \e \m \e \n \t \space \b \y \space \t \h \e \space \A \b \b \o \t \t \space \G \o \v \e \r \n \m \e \n \t \space \t \o \d \a \y \space \t \h \a \t \space \i \t \space \h \a \s \space \c \o \n \f \i \r \m \e \d \space \a \space \n \e \w \space \t \h \r \e \s \h \o \l \d \space \f \o \r \space \C \a \b \i \n \e \t \space \a \p \p \r \o \v \a \l \space \o \f \space \n \e \w \space \m \e \d \i \c \i \n \e \s " ..."]]
Read more →
Posted by Michael Wonder on 05 Aug 2015
The federal government's decision to list Keytruda, the breakthrough new cancer drug that rid businessman Ron Walker of terminal cancer, on the ...
Read more →
Posted by Michael Wonder on 05 Aug 2015
A drug to treat a potentially fatal brain condition caused by liver failure will be funded by the NHS following ...
Read more →
Posted by Michael Wonder on 05 Aug 2015
[:content [\8 \space \A \p \r \i \l \space \2 \0 \1 \4 \space \- \ \N \e \a \r \l \y \space \8 \5 \% \space \o \f \space \n \e \w \space \d \r \u \g \s \space \i \n \space \G \e \r \m \a \n \y \space \t \h \a \t \space \w \e \r \e \space \a \p \p \r \o \v \e \d \space \i \n \space \2 \0 \1 \1 \space \f \o \r \space \o \u \t \p \a \t \i \e \n \t \s \space \c \o \v \e \r \e \d \space \b \y \space \p \u \b \l \i \c " ..."]]
Read more →
Posted by Michael Wonder on 05 Aug 2015
The Australian Commission on Safety and Quality in Health Care (ACSQHC, the Commission) is developing a national standardised medication chart for PBS ...
Read more →
Posted by Michael Wonder on 05 Aug 2015
[:content [\1 \4 \space \M \a \r \c \h \space \2 \0 \1 \4 \space \- \ \S \e \v \e \r \e \l \y \space \i \l \l \space \p \a \t \i \e \n \t \s \space \a \n \d \space \t \h \o \s \e \space \w \i \t \h \space \r \a \r \e \space \d \e \b \i \l \i \t \a \t \i \n \g \space \c \o \n \d \i \t \i \o \n \s \space \c \o \u \l \d \space \b \e \space \g \i \v \e \n \space \n \e \w \space \m \e \d \i \c \i \n \e \s \space \y \e \a \r \s \space \b \e \f \o \r \e \space \t \h \e \y " ..."]]
Read more →
Posted by Michael Wonder on 05 Aug 2015
Novarts’ Xolair (omalizumab) has been recommended for routine use by the National Health Service as an add-on treatment for patients ...
Read more →
Posted by Michael Wonder on 05 Aug 2015
Australian biopharmaceutical company Specialised Therapeutics Australia (STA) is pleased to announce that Abraxane (nanoparticle albumin-bound paclitaxel) in combination with gemcitabine in ...
Read more →
Posted by Michael Wonder on 05 Aug 2015
PHARMAC invites proposals for the supply of national vaccine storage and distribution services to PHARMAC. ...
Read more →